NCT01145326

Functional Microarray Augmentation of Skin Treatment With Lidocaine

Functional Microarray Augmentation of Skin Treatment With Lidocaine (FAST Lidocaine)

• Status: Withdrawn
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of Oklahoma · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether co-application of a functional microarray of needles (FMA) speeds the rate at which topical anesthesia is provided. A secondary goal is to determine whether the depth of anesthesia is enhanced.

Detailed description

The study's primary goal is to determine whether co-application of a functional microarray of needles (FMA) speeds the rate at which topical anesthesia is provided by lidocaine gel 4% (LG4). A secondary goal is to determine whether the depth of anesthesia is enhanced.

Conditions

• Pain Perception
• Phlebotomy

Interventions

Type	Name	Description
DRUG	4% lidocaine gel application with sham microneedle device	Topical 4% lidocaine gel (LG4) applied to subject, after application of sham microneedle device (FMA).
DRUG	Microneedle-facilitated lidocaine application	Application of 4% lidocaine gel (LG4), after application of microneedle (FMA) device

Timeline

• Start date: 2015-01-01
• Primary completion: 2017-12-01
• Completion: 2017-12-01
• First posted: 2010-06-16
• Last updated: 2017-03-16

Locations

1 site across 1 country: United States